Clinical Opiate Withdrawal Scale (COWS)

Why use it

Objective quantification of opioid withdrawal severity enables safe, evidence-based initiation of buprenorphine (COWS ≥8 required to minimize precipitated withdrawal risk), appropriate methadone dosing in OTP programs, and monitoring of withdrawal-based detoxification. The COWS outperforms clinical impression alone in standardizing severity assessment and allows serial monitoring of symptom trajectory to guide dose adjustments.

About

The Clinical Opiate Withdrawal Scale (COWS) is a clinician-administered, 11-item validated scale for measuring the severity of opioid (opiate) withdrawal in both inpatient and outpatient settings. Developed by Wesson and Ling in 2003, it quantifies objective and subjective withdrawal signs and symptoms across physiological domains — autonomic, musculoskeletal, GI, and behavioral. The COWS total score stratifies severity from mild (5–12) to moderate (13–24), moderately severe (25–36), and severe (>36). It is the most widely used tool to guide initiation and dosing of medications for opioid use disorder (MOUD), particularly buprenorphine/naloxone (Suboxone), where induction must occur in the setting of moderate withdrawal (COWS ≥8–12) to prevent precipitated withdrawal.

When to use

• Pre-induction assessment before starting buprenorphine/naloxone — COWS ≥ 8 (traditionally ≥12 for safety) is required before first buprenorphine dose
• Serial monitoring during buprenorphine induction (traditional or low-dose "micro-induction" protocols)
• Emergency department patients presenting with opioid withdrawal
• Inpatient medically supervised opioid withdrawal (detoxification)
• OTP (Opioid Treatment Program) monitoring during methadone initiation
• Research studies involving opioid dependence, withdrawal, or MOUD

Formula

Pearls & pitfalls

• COWS ≥ 8 (some protocols ≥ 12) is required before first dose of buprenorphine to avoid PRECIPITATED WITHDRAWAL — a sudden, severe withdrawal syndrome caused by buprenorphine displacing full agonists from mu receptors.
• Precipitated withdrawal is a medical emergency: abrupt, severe withdrawal syndrome within 30–60 minutes of buprenorphine in patients with sufficient full agonist on board.
• Extended-release naltrexone (Vivitrol) also requires full opioid clearance — verify with COWS and/or urine drug screen (typically 7–10 days opioid-free, or 14 days for methadone).
• Low-dose buprenorphine induction (LDIBI/"micro-induction") does NOT require COWS ≥ 8 — this protocol starts with sub-milligram doses and incrementally increases while allowing other opioids concurrently.
• The COWS was validated specifically for SHORT-ACTING opioid withdrawal — longer-acting opioids (methadone, buprenorphine itself) produce delayed and prolonged withdrawal kinetics.
• Resting pulse rate should be measured BEFORE the assessment to obtain a baseline — recent activity inflates this item.
• Pupil size is one of the most reliable OBJECTIVE indicators of opioid withdrawal — midriasis (≥6 mm in normal light) is pathognomonic.
• Gooseflesh (piloerection) is among the most specific objective signs of opioid withdrawal — it cannot be voluntarily simulated.

Next steps

COWS 5–12 (Mild): Supportive care; comfort medications (clonidine, NSAIDs, antidiarrheals). Buprenorphine induction may be premature — reassess in 2–4 hours. COWS 13–24 (Moderate): Suitable for standard buprenorphine induction (≥8, ideally ≥12). Initiate with 2–4 mg buprenorphine/naloxone and reassess in 1–2 hours. COWS 25–36 (Moderately Severe): Standard buprenorphine induction; may require higher initial doses. Consider methadone protocol. COWS >36 (Severe): Medical monitoring required. High-dose buprenorphine or methadone initiation. IV fluids if dehydrated. Monitor for cardiac arrhythmia.

Evidence

Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253-259. Validated in opioid-dependent patients receiving buprenorphine and clonidine. Strong correlation with Visual Analog Scale (r = 0.87). Interrater reliability ICC = 0.93. Widely adopted by SAMHSA, ASAM, and APA as the standard clinical assessment for opioid withdrawal severity. Used in buprenorphine induction protocols across FQHC, ED, and OTP settings.

References

1. Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253-259. — link
2. Tompkins DA et al. Prospective assessment of nonmedical opioid use in patients treated for acute pain. J Pain. 2014;15(7):751-763. — link
3. SAMHSA. Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder. Advisory. 2015. — link